S-18886, the active isomer of S-18204, is a thromboxane A2 receptor antagonist with a long duration of action. The compound is under development by Servier for the potential treatment of cardiovascular diseases [269611]. By 2000, a clinical trial had been carried out in patients with coronary artery disease [389458]; advanced clinical trials were ongoing in August 2001 [420310].
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
s-18886 servier
4
servier s-18886
4
s-18886 active
4
active isomer
4
isomer s-18204
4
s-18204 thromboxane
4
thromboxane receptor
4
receptor antagonist
4
antagonist long
4
long duration
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!